CEVIDRA Laboratory manufactures the world’s only patented medical device that instantly neutralises skin penetration from many radionuclides - uranium, plutonium, americium, thorium, strontium, cesium, cobalt, silver, zirconium, manganese, antimony - therefore limiting both internal contamination and the need for extensive treatment. This medical device comes in the form of a dermatological emulsion containing calixarene to treat external contamination while reducing the radioactive effluent, and thus preventing cross contamination. Cevidra® cream is available since 2018 and has confirmed its efficacy on real contaminations in nuclear facilities, it has also received an award in "Nuclear Safety" category in the WNE 2018.
CEVIDRA laboratory, founded in 2006 in Grasse, is a French pharmaceutical laboratory specializing in nuclear decontamination and hospital prescription drugs to treat rare deseases.